Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

A legfontosabb adatok

Ki végzi
Hospital Moinhos de Vento
Hol
Brazília29 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Leállítva
Résztvevők
107 fő vett részt
Kezdés
2022. jan. 27.
Befejezés
2023. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Duration of therapy
A regiszteradat frissítve
2024. március 6.
Miért állt le
low recruitment rate

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki vehet részt

  • Infection's diagnosis while in the ICU
  • Severe infection in any site (defined as the presence of sepsis/septic shock or bloodstream infection or pneumonia) associated with a positive culture by MRD-GNB (Acinetobacter baumannii complex, Pseudomonas aeruginosa, and Enterobacterales bacteria, only susceptible to carbapenems and/or polymyxins)
  • Hemodynamically stable and afebrile (axillary temperature less than 37.8ºC) for at least 48 hours on day 7 of adequate antibiotic therapy
  • Consent of the team providing care to the patient regarding their inclusion in the research

Ki nem vehet részt

  • Inclusion in other experimental studies involving antimicrobial therapy
  • Positive blood cultures for the same pathogen within 48 hours prior to randomization, when collected
  • Uncontrolled concomitant infection with another GNB (regardless of susceptibility profile)
  • Previous inclusion in this study
  • Infections that have as the primary site: endocarditis/endovascular infection, necrotizing fasciitis, osteomyelitis, abdominal abscess or other abdominal infections requiring surgical intervention (except infections that have been treated surgically, with curative character within the first 3 days of appropriate antimicrobial therapy), central nervous system Infections, empyema, prosthetic infection
  • Immunosuppression defined as: neutrophil cells <1000/mm³ in the current hospitalization, HIV/AIDS diagnosis with last CD4 count <200/mm³, solid organ transplantation in the last year and/or need for increased immunosuppression due to acute rejection in the last year, hematopoietic stem cell transplantation in the last year, and/or current therapy for chronic graft-versus-host disease
  • Known pregnancy
  • Patient in palliative care who has already decided not to restart antimicrobials, if necessary, or hemodynamic support measures

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Antimicrobial resistance is a major global problem, particularly in hospital-acquired infections (HAIs). Gram-negative bacilli (GNB), including Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii, are among the most common pathogens associated with multidrug resistance and HAIs. These bacteria are of special concern because few therapeutic options are available.

A teljes eredeti leírásKevesebb

Traditionally, the duration of treatment for severe multidrug-resistant (MDR)-GNB infections is 14 days. Studies of severe infections by GNB, regardless of susceptibility profile, have shown that shorter antimicrobial treatments are not inferior to traditional durations of therapy and are associated with a lower incidence of adverse effects. However, there are currently no studies assessing whether shorter duration of antimicrobial treatment is effective for MDR-GNB.

This open-label, randomized clinical trial aims to assess the non-inferiority of 7-day antibiotic therapy compared to conventional 14-day treatment in severe infections by MDR-GNB.

A vizsgálat 2 csoportja

  • 7-day adequate antibiotic therapyA vizsgált kezelés

    Adequate antibiotic therapy is defined as antimicrobial treatment with at least one agent with in vitro susceptibility.

    Kezelés: Duration of therapy

  • 14-day adequate antibiotic therapyMár használt kezelés, összehasonlításként

    Adequate antibiotic therapy is defined as antimicrobial treatment with at least one agent with in vitro susceptibility.

    Kezelés: Duration of therapy

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Open-label, Randomized Clinical Trial to Assess the Non-inferiority of 7-day Antibiotic Therapy Compared to Conventional 14-day Treatment in Multidrug-resistant Gram-negative Bacilli Infections
A regiszteradat frissítve
2024. március 6.